Golden Grail Technology Subsidiary Accurate Venture Signs Distribution Agreement with Southwest Cancer Center

Highly Respected Cancer Center to Dispense bioRenovate® CBD Product

DEERFIELD BEACH, FL / ACCESSWIRE / March 29, 2017 / Golden Grail Technology Corp. (OTC PINK: GOGY) (“Golden Grail” or the “Company”), a technology and software solutions provider to companies with unique value propositions operating in mass market consumer sectors, is extremely pleased to announce the execution of a Medical Practice Distribution Agreement between its subsidiary Accurate Venture and Southwest Cancer Center at Florida Hospital in Orlando, Florida. The five-doctor practice is one of the most prestigious in the area and services thousands of patients.

In February 2016, Golden Grail Technology acquired Accurate Venture, which develops and markets specific consumer and pharmaceutical grade Hemp Cannabidiol (CBD) supplement products. Accurate has a large marketing database of customers and offers monthly subscriptions for most of its product line.

The Agreement reduces the cost of Accurate Venture’s bioRenovate 1500mg pharmaceutical grade CBD product for all Oncology patients under Southwest Cancer Centers’ care.

Dr. Sarah Katta, commented, “We are honored to have bioRenovate available here at Southwest Cancer Center. bioRenovate is the only true pharmaceutical grade cannabis product that I trust enough to give it to my patients. They are rigorously tested for quality and maintain the highest standards. This will improve the quality of life and help may patients who have very little hope otherwise. I’m pleased to offer it to our patient population.”

Chief Executive Officer, Bill Fisher commented, “Southwest Cancer Center is one of the most respected practices in the region and it’s more than an honor to have the practice on-board. This is the first in a long line of practices across the country that we are working diligently to get distribution deals signed with and add quality of life to patients across the entire United States.”

About Southwest Cancer Center

Southwest Cancer Center was established by Dr. Thomas Katta in 1984 and has been serving Orlando for 33 years. They specialize in Hematology/Oncology and are one of the highest rated practices in the region. There are five doctors and two locations in Orlando and they serve thousands of patients, 922 Lucerne Terrace Orlando FL 32806 and 7436 Docs Grove Circle Orlando FL 32819.

About bioRenovate 1500mg 1oz Sublingual Drops

bioRenovate 1500® is a 1500mg CBD sublingual tincture produced according to pharmaceutical grade standards and testing. It is available primarily through doctor’s offices and medical practices with on-line refills can be ordered according to the recommendations of the doctor. Cannabidiol from hemp is Federally legal to distribute across all 50 states, as it is not extracted from the plant that is legally classified as marijuana. bioRenovate products consist solely of parts of the cannabis plant excluded from the CSA definition of marijuana, and therefore are not included in the new drug code (7350) or in the drug code for marijuana (7360).

They are 3rd party verified by the most respected labs in the country and manufactured according to pharmaceutical standards and testing.

About Golden Grail Technology Corp.

Golden Grail Technology Corp. (GOGY) is a technology and software solutions provider to companies with unique value propositions operating in mass market consumer sectors such as jewelry, health and personal care, beauty, electronics, pet and animal supplies, sports and games. Golden Grail’s mission is to utilize their network of industry experts, who specialize in targeting areas of business that can be accelerated with technology, in order to give small companies an opportunity to compete with industry giants.

[Doctors recommending bioRenovate products, do so on their own. Accurate Venture and Golden Grail Technology do not make claims of any specific benefits. The Food and Drug Administration has not evaluated representations regarding the efficacy and safety of bioRenovate products. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease.]

For more information, please visit: http://goldengrailtechnology.com, http://accurateventure.com, http://biorenovate.com

Forward-Looking Statements

Except for the historical and present factual information contained in this press release, the matters discussed in this press release, including statements identified by words such as “will,” “expected,” “plans,” and similar expressions are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements, including the factors described in filings with OTC Markets, including but not limited to discussion under the caption “Risk Factors.” Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s judgment solely as of the date hereof.

Contact Information

Hayden IR
(917) 658-7878
hart@haydenir.com

SOURCE: Golden Grail Technology Corp.

ReleaseID: 458411